Filters

2019 - 20202

More filters

2021 - 20222
Reset filters

Settings

search.filters.applied.f.access: openAccess × Subject: Alzheimer's disease ×

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Biochemical Characterization of Mouse Retina of an Alzheimer's Disease Model by Raman Spectroscopy
    (Washington, DC : ACS Publications, 2020) Stiebing, Clara; Jahn, Izabella J.; Schmitt, Michael; Keijzer, Nanda; Kleemann, Robert; Kiliaan, Amanda J.; Drexler, Wolfgang; Leitgeb, Rainer A.; Popp, Jürgen
    The presence of biomarkers characteristic for Alzheimer's disease in the retina is a controversial topic. Raman spectroscopy offers information on the biochemical composition of tissues. Thus, it could give valuable insight into the diagnostic value of retinal analysis. Within the present study, retinas of a double transgenic mouse model, that expresses a chimeric mouse/human amyloid precursor protein and a mutant form of human presenilin 1, and corresponding control group were subjected to ex vivo Raman imaging. The Raman data recorded on cross sections of whole eyes highlight the layered structure of the retina in a label-free manner. Based on the Raman information obtained from en face mounted retina samples, a discrimination between healthy and Alzheimer's disease retinal tissue can be done with an accuracy of 85.9%. For this a partial least squares-linear discriminant analysis was applied. Therefore, although no macromolecular changes in form of, i.e., amyloid beta plaques, can be noticed based on Raman spectroscopy, subtle biochemical changes happening in the retina could lead to Alzheimer's disease identification. ©
  • Thumbnail Image
    Item
    Significant Upregulation of Alzheimer's β-Amyloid Levels in a Living System Induced by Extracellular Elastin Polypeptides
    (Weinheim : Wiley-VCH, 2019) Ma, Chao; Su, Juanjuan; Sun, Yao; Feng, Yang; Shen, Nolan; Li, Bo; Liang, Yingxia; Yang, Xintong; Wu, Hui; Zhang, Hongjie; Herrmann, Andreas; Tanzi, Rudolph E.; Liu, Kai; Zhang, Can
    Alzheimer's disease (AD) is a neurodegenerative disorder and the primary cause of age-related dementia. The etiology of AD is complex and has not been completely elucidated. Herein, we report that treatment with elastin-like polypeptides (ELPs), a component of the brain extracellular matrix (ECM), significantly increased the levels of AD-related amyloid-β peptides (Aβ) both in vitro and in vivo. Regarding the molecular mechanism(s), the upregulation of Aβ levels was related to increased proteolytic processing of the amyloid precursor protein. Furthermore, nesting tests demonstrated that the ELP-treated animals showed significant neurobehavioral deficits with cognitive impairment. These results suggest that the elastin is associated with AD-related pathological and behavioral changes. This finding presents a new aspect for Alzheimer's amyloidosis event and provides a great promise in developing ELP-based model systems to better understand the pathogenesis of AD. © 2019